--- title: "PureTech Health 確認了關於收購的猜測" description: "PureTech Health 週一確認正在與私募股權公司 Nordic Capital 進行潛在全現金收購的談判。該公司表示,目前尚不確定這些討論是否會導致正式報價,或任何潛在提案的條款是什麼。它補充道,Nordic Capital 必須在 5 月 5 日之前明確其意圖。根據公司聲明,此次公告是在未獲得 Nordic Capital 同意的情況下發布的" type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/234862568.md" published_at: "2025-04-07T17:00:50.000Z" --- # PureTech Health 確認了關於收購的猜測 > PureTech Health 週一確認正在與私募股權公司 Nordic Capital 進行潛在全現金收購的談判。該公司表示,目前尚不確定這些討論是否會導致正式報價,或任何潛在提案的條款是什麼。它補充道,Nordic Capital 必須在 5 月 5 日之前明確其意圖。根據公司聲明,此次公告是在未獲得 Nordic Capital 同意的情況下發布的 PureTech Health 週一確認正在與私募股權公司 Nordic Capital 進行潛在全現金收購的談判。 根據公司所述,目前尚不確定這些討論是否會導致正式報價,或任何潛在提案的條款是什麼。 它補充説,Nordic Capital 必須在 5 月 5 日之前明確表明其意圖。 根據公司聲明,此公告是在未獲得 Nordic Capital 同意的情況下發布的。 ### Related Stocks - [PRTC.US - PureTech Health](https://longbridge.com/zh-HK/quote/PRTC.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | PureTech Health Reports Phase 2b Data Showing Deupirfenidone Safe and Effective in Older IPF Patients | PureTech Health plc has reported positive Phase 2b ELEVATE IPF trial results for deupirfenidone (LYT-100), showing it is | [Link](https://longbridge.com/zh-HK/news/262166578.md) | | PureTech Health Announces Positive Phase 2b Extension Data for Deupirfenidone in IPF; Phase 3 Trial Design Update Expected Q4 2025 | PureTech Health plc announced positive results from the Phase 2b extension of its ELEVATE IPF trial for deupirfenidone i | [Link](https://longbridge.com/zh-HK/news/259261218.md) | | BUZZ-UK's PureTech climbs after successful US FDA meeting | Shares of PureTech Health (PRTC.L) up 4.1% at 127pStock among top gainers on FTSE Small Cap index (.FTSC) , which is fla | [Link](https://longbridge.com/zh-HK/news/268919041.md) | | PureTech Health Cash Runway Extended | PureTech Health reported a cash balance of nearly $320 million for Q2 2025, down from $367 million in FY 2024, primarily | [Link](https://longbridge.com/zh-HK/news/255673346.md) | | REG - PureTech Health PLC Citigroup Inc - Holding(s) in Company | Citigroup Inc. has crossed a threshold in its holdings of PureTech Health PLC, with a total voting rights percentage of | [Link](https://longbridge.com/zh-HK/news/266421005.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。